Grants and Contributions:

Back to search

Title:

SARS-CoV-2 Point of Care Test Development

Agreement Number:

Agreement Value:

$1,331,809.00

Agreement Date:

Jun 18, 2020 - Sep 30, 2021

Description:

This project is to develop and qualify a rapid Point-of-Care diagnostic test for the SARS-CoV-2 virus that causes Covid-19. The test will be run on a portable reader that will be capable of operating in a clinic or in the field using a battery power source.

Organization:

National Defence

Location:

Toronto, Ontario, CA M9W 4Z4

Reference Number:

180-2021-2022-Q1-R&D-001

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Type:

Other

Amendment Date

Jun 30, 2021

Recipient's Operating Name:

Custom Biologics

Recipient's Legal Name:

MJMG Holdings Inc.

Program:

Innovation for Defence Excellence and Security Program - Innovation Netowrks

Program Purpose:

Collaborate with academic and private sector partners to build a network of expertise to support Canada’s current and future defence and security needs.

Amendments:

See Amendments